Park Ha Biological Technology is trading 6.1% down at $0.44 after shareholders approved sweeping governance and capital structure changes on July 13.
- The company gained authority to massively expand authorized share capital and increase Class B voting rights from 20 to 100 votes per share.
- The approved changes also allow for large-scale share consolidations and subdivisions, moves that appear to be weighing on investor sentiment.